MYOM2 and plasma cell myeloma: Before developing active myeloma, patients undergo two asymptomatic precursor disease stages, namely monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM), which are characterized by the presence of an M-protein in the serum and/or excess bone marrow (BM) plasma cells [2].